The central moter dysfunction associated with stroke, cerebrospinal injury, cerebrospinal tumor and neuromusclar disease
Conditions
Interventions
The treatment of functional recovery using HAL for single joint or HAL for lower limb, about 2 times for a week.
Sponsors
University of Tsukuba
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients can consent by a document. If the handwriting is difficult due to the primary disease, it is assumed to obtain a document consent from ghost-writing user. 2. Patients 16 years of age or older. The consent of the legal representative's is needed for the patients of minors 16-20 years of age. 3. Patients who are hospitalized in the general ward, ICU or HCU. 4. Patients can wear HAL, weighing 40-100 kg, height is 150-190 cm. 5. Patients who can be hospitalized continuously along the test schedule.
Exclusion criteria
Exclusion criteria: 1. It is difficult to perform the volantary movement of the limbs in accordance with the instructions due to the disturbance of consciousness or dementia. 2. It is difficult to wear HAL or train using HAL due to the severe deformation of the skeletal system. 3. Patients has a complication, which can disturb the treatment using HAL. 4. The biological edectrode for HAL can not be affixed to patient's skin due to the skin disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Adverse event 2. Failure of HAL and ancillary equipment 3. Feasibility of study protocol | — |
Countries
Japan
Contacts
Public ContactAiki Marushima
Faculty of Medicine, University of Tsukuba Division of Clinical Medicine, Department of Neurosurgery, Emergency and Critical Care Medicine
Outcome results
None listed